NICE rules out cannabis product on prescription in UK

The cannabis-based drug initially approved for use on the NHS in Wales should not be made available on prescription to treat muscle spasms in MS patients, according to NICE guidance.

Cannabis: NHS use of oral spray ruled out by NICE
Cannabis: NHS use of oral spray ruled out by NICE

In its updated guidance for treating MS released on Wednesday, NICE said the drug nabiximols (Sativex), an oral spray derived from the class B drug, was ‘not a cost effective treatment’ and clinicians should not offer it to patients.

The decision comes just two months after the drug was approved for use on the NHS in Wales. The NICE guidance overrules this recommendation, meaning new patients across the UK, including Wales, will not be able to receive the drug on the NHS.

The recommendation does not apply to any patients who may have already started treatment with Sativex, who should be able to continue treatment ‘until they and their NHS clinician think it appropriate to stop’, according to the guidance.

NICE recommends baclofen or gabapentin as first-line options to treat muscle spasms in MS patients, or a combination of the two treatments depending on a case-by-case basis. Tizandine and dantrolene were recommended as second-line options.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NICE publishes rapid guidance on managing COVID-19 in primary care

NICE publishes rapid guidance on managing COVID-19 in primary care

New guidance on symptom management in patients with suspected and confirmed COVID-19...

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

As the coronavirus crisis continues, we at Haymarket are constantly seeking new ways...

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Around one in four GPs are self isolating - many of them unnecessarily - as frontline...

Cashflow fears for locums as government relaxes 10-week pension rule

Cashflow fears for locums as government relaxes 10-week pension rule

Locums will have longer to declare pensionable income under plans to relax a 10-week...

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs who have retired or no longer hold a licence to practise are...

Updated PHE advice on PPE backs eye protection for GPs

Updated PHE advice on PPE backs eye protection for GPs

GPs should wear eye protection in addition to a mask, gloves and apron when providing...